Evaluation of sofosbuvir plus daclatasvir combination for hepatitis C virus treatment

被引：0
作者：
Moron Romero, Rocio [1 ]
Diaz, Xando [1 ]
del Carmen Gonzalez, Maria [1 ]
Rodriguez, Alejandro [1 ]
Casas, Inmaculada [1 ]
Cabeza, Jose [1 ]
机构：
[1] Complejo Hosp Univ Granada, Pharm, Granada, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2017年 / 39卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PT028
引用
收藏
页码：331 / 331
页数：1
相关论文
共 50 条
[31]   Sofosbuvir for the treatment of hepatitis C virus [J].
Asselah, Tarik .
EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (01) :121-130
[32]   An evaluation of ledipasvir plus sofosbuvir for the treatment of chronic hepatitis C infection [J].
Balatow, Pearson ;
Sandlin, Amber ;
Cory, Theodore James .
EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (14) :1839-1846
[33]   Treatment Failure With Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Treatment Naive Patients With Chronic Hepatitis C Without Cirrhosis [J].
Afzal, Muhammad ;
Tarar, Shahida Husain ;
Shah, Syed Muhammad Ali ;
Butt, Zamir ;
Ajmal, Muhammad ;
Younis, Irfan ;
Talat, Syed Usama ;
Akhtar, Hina ;
Ali, Javeria .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 :S560-S561
[34]   End Treatment Response and Sustained Viral Response in Patients With Hepatitis C Virus Receiving Sofosbuvir and Daclatasvir [J].
Rahman, Attiya S. ;
Amir, Muhammad ;
Jamal, Qaiser ;
Riaz, Mehwish ;
Fareed, Komal ;
Siddiqui, Muhammad .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
[35]   Safety and Efficacy of Sofosbuvir Plus Ribavirin and Sofosbuvir Plus Daclatasvir With or Without Ribavirin Combinations in Children and Adolescents With Chronic Hepatitis C [J].
Hassan, Adil ;
Bughio, Ubedullah ;
Bhatti, Rehmatullah ;
Ali, Mashooque ;
Jamali, Laraib ;
Sadik, Muhammad .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 :S592-S592
[36]   Daclatasvir for the treatment of hepatitis C virus infection [J].
Adler, Hugh ;
Lambert, John S. .
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) :725-738
[37]   Ledipasvir/Sofosbuvir versus Daclatasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Genotype 4 Patients [J].
Abdelaty, Lamiaa N. ;
Elnaggar, Ahmed A. ;
Said, Amira A. ;
Hussein, Raghda R. S. .
CURRENT DRUG SAFETY, 2020, 15 (01) :53-60
[38]   Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis [J].
El Kassas, Mohamed ;
Abdeen, Nermeen ;
Omran, Dalia ;
Alboraie, Mohamed ;
Salaheldin, Mohamed ;
Eltabbakh, Mohamed ;
Farghaly, Rasha ;
Emadeldeen, Mohammed ;
Afify, Shimaa ;
Sweedy, Ahmad ;
Ghalwash, Ahmed ;
Abbass, Amr ;
Ezzat, Sameera ;
Tahoon, Marwa ;
ELshazly, Helmy M. ;
Hamdy, Hassan ;
Omar, Heba .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) :E877-E882
[39]   Compare the Efficacy of Sofosbuvir Plus Ribavirin Verus Sofosbuvir Plus Daclatasvir in Patients with Chronic C Hepatitis Genotype 2 Infection [J].
Chang, Kuo-Chin ;
Hu, Tsung-Hui ;
Chen, Chien Hung ;
Wang, Jing-Houng .
HEPATOLOGY, 2018, 68 :586A-586A
[40]   Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis [J].
El Kassas, Mohamed ;
Abdeen, Nermeen ;
Omran, Dalia ;
Alboraie, Mohamed ;
Salaheldin, Mohamed ;
Eltabbakh, Mohamed ;
Farghaly, Rasha ;
Emadeldeen, Mohammed ;
Afify, Shimaa ;
Sweedy, Ahmad ;
Ghalwash, Ahmed ;
Abbass, Amr ;
Ezzat, Sameera ;
Tahoon, Marwa ;
ELshazly, Helmy M. ;
Hamdy, Hassan ;
Omar, Heba .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 :E877-E882
12345